Evaluation of Vascular Health Profile in Predicting Venous Thromboembolism

Site Image

Study Overview

The main goal of this study is to utilize previously validated cytometric markers of to identify cancer patients at high risk of VTE. The primary outcome will be DVT or pulmonary embolism (PE). Patients with pancreatic and brain cancer will be enrolled as these patients are known to have higher rates of VTE relative to other forms of cancer. Patients will receive a screening duplex ultrasound, interval 3 month ultrasound for asymptomatic DVT and will be followed longitudinally for one year. Blood will be collected during the initial screening, at the three month interval follow-up (at time of second ultrasound) and any VTE event over the course of the year for cytometric analysis and MP TF activity.

  • Study Identifier: 820651

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email psom-ocr@pobox.upenn.edu